As IFITM1 has been shown to be increased in cervical, esophageal, ovarian, brain and colon cancers [27–31], we analyzed the expression of IFITM1 in multiple patient-derived colorectal cancer cell lines by immunoblot. The gene discussed is IFITM1; the disease is malignant colon neoplasm.